Macrocure Hires Lewis Gryziewicz as Vice President, Regulatory Affairs
04 mai 2015 08h00 HE
|
Macrocure
PETACH TIKVA, Israel, May 4, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and...
Macrocure Ltd. to Participate in Upcoming Annual Meeting of The Association for Research in Vision & Ophthalmology (ARVO)
28 avr. 2015 08h00 HE
|
Macrocure
PETACH TIKVA, Israel, April 28, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure Ltd. Announces First Quarter 2015 Financial Results Date and Conference Call
21 avr. 2015 08h00 HE
|
Macrocure
PETACH TIKVA, Israel, April 21, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure Ltd. to Participate in Upcoming Symposium on Advanced Wound Care
13 avr. 2015 09h00 HE
|
Macrocure
PETACH TIKVA, Israel, April 13, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure Ltd. Provides Corporate Update and Reports Fourth Quarter and Full Year 2014 Financial Results
17 mars 2015 16h05 HE
|
Macrocure
—Company announces anticipated timeline for DFU Phase III clinical trial results—
—Company accelerates timelines for VLU Phase III clinical trial...
Macrocure Hires Dr. Ramesh Tharuvai, Ph.D. as Vice President, Operations
02 mars 2015 06h00 HE
|
Macrocure
PETACH TIKVA, Israel, March 2, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
Macrocure Ltd. Announces Fourth Quarter and Full Year 2014 Financial Results Date and Conference Call
25 févr. 2015 08h00 HE
|
Macrocure
PETACH TIKVA, Israel, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure Hires Mark Page as Chief Financial Officer
09 févr. 2015 04h05 HE
|
Macrocure
PETACH TIKVA, Israel, Feb. 9, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
Macrocure Announces Special General Meeting of Shareholders for Approval of Amendments to Compensation Package of CEO and 2013 Share Incentive Plan
05 févr. 2015 12h00 HE
|
Macrocure
PETACH TIKVA, Israel, Feb. 5, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
Macrocure Ltd. to Present at 17th Annual BIO CEO & Investor Conference
27 janv. 2015 08h00 HE
|
Macrocure
PETACH TIKVA, Israel, Jan. 27, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...